Parametrica Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Parametrica Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-928	Closed	-$462K	–	78
2022 Q2	$462K	Buy	928 +404	+77%	+$210K	0.5%	43
2022 Q1	$296K	Buy	+524	New	+$316K	0.22%	122
2020 Q4	–	Sell	-435	Closed	-$224K	–	162
2020 Q3	$224K	Buy	+435	New	+$220K	0.42%	71
2019 Q2	–	Sell	-1,079	Closed	-$330K	–	16
2019 Q1	$330K	Buy	+1,079	New	+$291K	0.7%	38
2017 Q3	–	Sell	-1,288	Closed	-$291K	–	352
2017 Q2	$291K	Sell	1,288 -592	-31%	-$129K	0.27%	141
2017 Q1	$375K	Buy	1,880 +606	+48%	+$117K	0.39%	85
2016 Q4	$232K	Buy	+1,274	New	+$217K	0.23%	156
2016 Q3	–	Sell	-2,669	Closed	-$382K	–	140
2016 Q2	$382K	Buy	+2,669	New	+$381K	0.57%	43

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return